EUPATI Prepares to Celebrate 5th Anniversary in Brussels
EUPATI celebrates its 5th Anniversary in Brussels by staging a free workshop.
As the fifth anniversary of the European Patients’ Academy (EUPATI) approaches, the organization is getting to stage a free workshop, “All Aboard to a Better Health Future”, to be held in Brussels on December 14th.
According to a statement from EUPATI, “Patient involvement in medicines research and development is a major driving force for transformational change in healthcare and the development of innovative medicines. This is why the EUPATI Project is such an exciting and unique opportunity – offering patients and patient advocates education and information on how new therapies are being developed and regulated.”
EUPATI works at the national level, implementing initiatives in 18 countries. The national teams offer workshops and tutorials for patient groups, interacting with professionals from clinical research, ethics committees, regulators, and the pharmaceutical industry.
“The challenge now is to bring all these initiatives and experiences together to create value for everyone. For the patient this means better understanding of research and innovation, leading to better therapies and eventually to improved health and well being,” EUPATI noted.
EUPATI is a pan-European Innovative Medicines Initiative (http://www.imi.europa.eu/) project of 33 organizations, led by the European Patients’ Forum, with partners from patient organizations (the European Genetic Alliance, the European AIDS Treatment Group, and EURORDIS), universities and not-for-profit organizations, along with a number of pharmaceutical companies.
Landmark Phase III Trial Shows Keytruda Significantly Improves Event-Free Survival in LA-HNSCC
April 28th 2025Interim KEYNOTE-689 trial data show that perioperative Keytruda significantly lowers the risk of disease progression or recurrence in resectable, locally advanced head and neck squamous cell carcinoma, marking the first major clinical advance for this patient population in more than two decades.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
